Loss of Central Nervous System Component of Dopaminergic Inhibition of Prolactin Secretion in Patients with Prolactin-Secreting Pituitary Tumors
The administration of l-dopa suppresses prolactin (PRL) secretion in normal subjects and in patients with hyperprolactinemia, although it is not known whether this effect, which requires the conversion of dopa to dopamine, is mediated peripherally or through the central nervous system. To distinguis...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1978
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372615/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/659585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109022 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|